Head and neck cancer staging and prognosis: perspectives of the UICC and the AJCC

B O'Sullivan, JP Shah, WM Lydiatt - Head and neck cancer: multimodality …, 2016 - Springer
The prognosis of head and neck cancer is determined by numerous factors related to the
patient, tumor, and health-care system. For many measures of outcomes, especially the key …

[引用][C] 手术后^(131) I 联合甲状腺激素治疗分化型甲状腺癌的临床研究

石福兴, 廖宁, 谭介恒, 陈汉华, 彭伟炜 - 广西医学, 2011

Radioiodine therapy of differentiated thyroid cancer

E Seregni, A Mallia, C Chiesa, G Scaramellini… - … Therapy: Principles and …, 2013 - Springer
The incidence of thyroid carcinomas is steadily increasing. Primary tumors of the thyroid
gland include carcinomas that originate from epithelial cells (carcinomas of thyrocytes and C …

[引用][C] 甲状腺球蛋白测定与^ 131 碘全身扫描对分化型甲状腺癌^ 131 碘治疗后的随访价值郭一玲张英男陈佐伟冯程辛镇祓

郭一玲, 张英男, 陈佐伟, 冯程, 辛镇祓 - 中国基层医药, 2013

[引用][C] 促甲状腺激素在分化型甲状腺癌诊治中的应用

刘松, 王圣应 - 中华内分泌外科杂志, 2013

[引用][C] 对分化型甲状腺癌在^(131) I 治疗后随访工具的评价

郭一玲, 张英男, 陈佐伟, 冯程, 辛镇祓 - 中国医学工程, 2012

The utility of peripheral thyrotropin receptor mRNA in the management of differentiated thyroid cancer

A Aliyev, S Soundararajan, E Bucak, M Gupta… - Surgery, 2015 - Elsevier
Background Our aim was to analyze the utility of peripheral thyrotropin receptor (TSHR)
messenger RNA (mRNA) in predicting and detecting the recurrence of differentiated thyroid …

[HTML][HTML] Effects of recombinant human thyroid stimulating hormone on 131I therapy for the treatment of differentiated thyroid cancer

Y Guo, Y Zhang, Z Chen, Z Xin - Experimental and …, 2015 - spandidos-publications.com
The aim of the present study was to compare the advantages and disadvantages of the
combined application of recombinant human thyroid stimulating hormone (rhTSH) with …

Bone metastases from differentiated thyroid carcinoma

JA Wexler - Thyroid Cancer: A Comprehensive Guide to Clinical …, 2016 - Springer
Thyroid cancer incidence has been increasing for decades in the United States. There are
known risk factors for thyroid cancer including female gender, advancing age, family history …

[引用][C] ^(131) I 治疗分化型甲状腺癌后定期随访指标的临床评价

郭一玲, 陈佐伟, 张英男, 冯程, 辛镇祓 - 现代肿瘤医学, 2014